UC San Diego to Treat Autism With CBD in Landmark Study

uc-san-diego-marijuana-study-autism.jpg

CBD (Cannabidiol) is widely considered to be the sorcerer's stone compound in cannabis. The non-psychoactive and therapeutic component has been shown to cease seizures, stall breast cancer, and has been hailed by Dr. Sanjay Gupta.

Now, our neighbors at UC San Diego will discover if CBD can successfully treat the 3.5 million Americans that suffer from autism. Researchers will spend time examining the results of CBD-treatment on children 8-12 years old suffering from a severe form of this developmental brain disorder.

The landmark study was made possible by a $4.7 million grant from the Noorda Foundation in partnership with the Wholistic Research and Education Foundation based in La Jolla. The donation is the largest private research donation to study CBD in America.

The group says its goal is

"to change this paradigm with research-driven, scientific data, while also supporting the establishment of standardized testing and regulation to ensure that available products are indeed what they claim to be."

To achieve that goal, UC San Diego's Center for Medical Cannabis Research will examine the affect of CBD on 30 autistic children with "severe symptoms". Those 30 children will receive a liquid form of CBD sourced from a federally approved lab in Arizona.

Researchers will then discover how CBD can aid in the symptoms that include "seizures, self-injuring behavior, and crippling anxiety." While case studies in the past have offered clearcut proof that CBD can halt seizures, this controlled study will offer empirical evidence into CBD's powers fighting autism.

President of the Autism Society Scott Badesch told the Duluth News Tribune that

"I've spoken to parents who swear that this is effective — but it needs to undergo scientific research."

The study at UC San Diego will be led by Dr. Igor Grant. On a higher level, the study serves to examine

"whether and how CBD alters brain activity, neurotransmitters and/or brain network connectivity; and determine whether biomarkers or neuroinflammation are altered by CBD."

To that effect, the 30 children will be subject to MRI scans and electroencephalograms to conclude whether or not CBD altered their brain chemistries.

Dr. Doris Trauner, a UC San Diego pediatrics and neuroscience expert also leading the study, added that

"It's important to do this study to show whether there is objective improvement, or whether is detrimental or whether it doesn't do anything at all" [Duluth News Tribune]

We can't wait to see the results from this monumental study in our backyard!